Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance

Autor: Abdulelah F. Bassas, Kyong Soo Park, Kyung Cheul Shin, A Young Kim, Xuebo Pan, Jae Bum Kim, Reem M. Sallam, Assim A. Alfadda, Yoon Jeong Park, Aimin Xu, Soo Heon Kwak
Rok vydání: 2015
Předmět:
DNA (Cytosine-5-)-Methyltransferase 1
Chromatin Immunoprecipitation
medicine.medical_specialty
Blotting
Western

General Physics and Astronomy
Adipose tissue
Biology
Real-Time Polymerase Chain Reaction
environment and public health
DNA methyltransferase
Article
General Biochemistry
Genetics and Molecular Biology

Proinflammatory cytokine
Mice
Insulin resistance
3T3-L1 Cells
Internal medicine
medicine
Animals
Humans
DNA (Cytosine-5-)-Methyltransferases
Obesity
RNA
Messenger

Promoter Regions
Genetic

Inflammation
Multidisciplinary
Adiponectin
urogenital system
nutritional and metabolic diseases
General Chemistry
DNA Methylation
medicine.disease
Molecular biology
Real-time polymerase chain reaction
Endocrinology
Adipose Tissue
embryonic structures
DNA methylation
DNMT1
Cytokines
Receptors
Leptin

Insulin Resistance
hormones
hormone substitutes
and hormone antagonists
Zdroj: NATURE COMMUNICATIONS(6)
Nature Communications
ISSN: 2041-1723
DOI: 10.1038/ncomms8585
Popis: Adiponectin plays a key role in the regulation of the whole-body energy homeostasis by modulating glucose and lipid metabolism. Although obesity-induced reduction of adiponectin expression is primarily ascribed to a transcriptional regulation failure, the underlying mechanisms are largely undefined. Here we show that DNA hypermethylation of a particular region of the adiponectin promoter suppresses adiponectin expression through epigenetic control and, in turn, exacerbates metabolic diseases in obesity. Obesity-induced, pro-inflammatory cytokines promote DNMT1 expression and its enzymatic activity. Activated DNMT1 selectively methylates and stimulates compact chromatin structure in the adiponectin promoter, impeding adiponectin expression. Suppressing DNMT1 activity with a DNMT inhibitor resulted in the amelioration of obesity-induced glucose intolerance and insulin resistance in an adiponectin-dependent manner. These findings suggest a critical role of adiponectin gene epigenetic control by DNMT1 in governing energy homeostasis, implying that modulating DNMT1 activity represents a new strategy for the treatment of obesity-related diseases.
The hormone adiponectin is produced by fat cells and has positive metabolic effects. Here, Kim et al. show that DNA methyltransferase 1 (DNMT1) represses adiponectin expression through hypermethylation of its promoter, and that inflammatory cytokines enhance DNMT1 activity in obese mice and humans.
Databáze: OpenAIRE